Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 12, 2023, titled "Ichnos Sciences Enters Licensing Agreement For OX40 Antagonist Monoclonal Antibody Portfolio with Astria Therapeutics".
Press Release Oct 12 2023
Filed with NSE · · 3 pages · English
Release
Glenmark Pharmaceuticals Limited on 6ix
Earlier from Glenmark Pharmaceuticals
- Press Release Sep 27 2023
- Press Release Sep 21 2023
- Press Release Aug 17 2023
- Press Release Aug 01 2023
- Press Release May 19 2023
Later from Glenmark Pharmaceuticals
- Glenmark Pharmaceuticals Limited Press Release Oct 17 2023
- Press Release Oct 18 2023
- Glenmark Pharmaceuticals Limited Press Release Nov 07 2023
- Press Release Nov 10 2023
- Glenmark Pharmaceuticals Limited Press Release Jan 03 2024
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals